Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Other financing activities (2018 - 2022)

Puma Biotechnology (PBYI) has disclosed Other financing activities for 3 consecutive years, with $69000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Other financing activities fell 96.39% year-over-year to $69000.0, compared with a TTM value of $69000.0 through Sep 2023, down 96.74%, and an annual FY2022 reading of $277000.0, down 85.5% over the prior year.
  • Other financing activities was $69000.0 for Q4 2022 at Puma Biotechnology, up from $53000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.9 million in Q4 2021 and bottomed at $9000.0 in Q4 2018.
  • Average Other financing activities over 3 years is $439200.0, with a median of $69000.0 recorded in 2022.
  • Peak annual rise in Other financing activities hit 96.39% in 2022, while the deepest fall reached 96.39% in 2022.
  • Year by year, Other financing activities stood at $9000.0 in 2018, then skyrocketed by 21122.22% to $1.9 million in 2021, then crashed by 96.39% to $69000.0 in 2022.
  • Business Quant data shows Other financing activities for PBYI at $69000.0 in Q4 2022, $53000.0 in Q3 2022, and $155000.0 in Q1 2022.